Search results
From Glioblastoma Treatments
Jump to navigationJump to search
- This access level includes treatments and approaches that are well-established within c [[Category:Access]] ...248 bytes (30 words) - 08:24, 11 November 2024
- This access level includes innovative or emerging therapies that are less commonly avai [[Category:Access]] ...319 bytes (40 words) - 08:49, 11 November 2024
- {{#ask: [[Has Access::Research It Yourself]]|?Belongs to Grouping|format=list|sep=,}} ...235 bytes (21 words) - 17:21, 11 November 2024
- [[Has Access::Standard Oncology]] ...261 bytes (29 words) - 21:23, 20 November 2024
- [[Has Access::Research It Yourself]] ...507 bytes (61 words) - 18:54, 27 November 2024
- [[Has Access::Research It Yourself]] ...691 bytes (80 words) - 08:41, 11 November 2024
- [[Has Access::Research It Yourself]] ...715 bytes (85 words) - 10:53, 11 November 2024
- ...ising candidate for further research. Additionally, an NIH-funded Expanded Access Protocol is providing MN-166 to ALS patients to evaluate its impact on neur .../news-releases/news-release-details/medicinova-support-nih-funded-expanded-access-clinical-trial) ...4 KB (455 words) - 19:58, 23 February 2025
- patients this is at best a last resort. What is needed instead is access to the most ...83 KB (12,417 words) - 11:04, 1 January 2025
